Vir Biotechnology Inc (VIR) returns
Vir Biotechnology returns over 5 years
$1,000 invested in Vir Biotechnology five years ago was worth $299.50 at the close on October 30, 2026, with dividends reinvested: an average return of -21.4% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +1.1% | — | $1,011 | -0.9% |
| 3 months | +27.0% | — | $1,270 | +2.1% |
| Year to date | +87.4% | — | $1,874 | +11.7% |
| 1 year | +90.6% | — | $1,906 | +12.4% |
| 3 years | +40.4% | +12.0% | $1,404 | +88.5% |
| 5 years | -70.1% | -21.4% | $299.50 | +76.0% |
Vir Biotechnology return by calendar year
| Year | VIR | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +87.4% | +11.7% | +75.7% |
| 2025 | -17.8% | +17.7% | -35.6% |
| 2024 | -27.0% | +24.9% | -51.9% |
| 2023 | -60.3% | +26.2% | -86.4% |
| 2022 | -39.6% | -18.2% | -21.4% |
| 2021 | +56.3% | +28.7% | +27.6% |
| 2020 | +113.0% | +18.4% | +94.6% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: VIR financials
No forecast, no recommendation. This page describes Vir Biotechnology Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.